MetaCap

BioCryst Pharmaceuticals (BCRX) News

NASDAQ: BCRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

7.22-0.10 (-1.37%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BCRX news summary

We found 11 recent headlines mentioning BioCryst Pharmaceuticals (BCRX): 0 in the past week and 7 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, BCRX is down 1.37% at $7.22. The most recent story, "BioCryst Presents New Real-World Evidence Showing Reduced Angioedema-Related Medical Visits After Switching to ORLADEYO® (berotralstat) at ACAAI 2026 Annual Scientific Meeting", was published by GlobeNewswire on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest BioCryst Pharmaceuticals headlines

Stocks mentioned alongside BCRX

Compare BCRX